Vimentin is a novel anti-cancer therapeutic target
Page 1 of 1
Vimentin is a novel anti-cancer therapeutic target
Lahat G, Zhu QS, Huang KL, Wang S, Bolshakov S, Liu J, Torres K, Langley RR, Lazar AJ, Hung MC, Lev D. Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One. 2010 Apr 16;5(4):e10105.
Similar topics
» Vimentin is a novel AKT1 target mediating motility and invasion
» E2F8 as a Novel Therapeutic Target for Lung Cancer
» Identification of a primary target of thalidomide teratogenicity
» Identification of p53-target genes in Danio rerio
» Axonal filopodial asymmetry induced by synaptic target
» E2F8 as a Novel Therapeutic Target for Lung Cancer
» Identification of a primary target of thalidomide teratogenicity
» Identification of p53-target genes in Danio rerio
» Axonal filopodial asymmetry induced by synaptic target
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum